Big news from Enantis
At In-Cosmetics Global 2026 in Paris, we announced a strategic distribution partnership with SOLLICE BIOTECH, bringing our technologies closer to real-world cosmetic applications.
We are proud to see our GF-STAB technology entering the market under the name RegeNova®- XF2.
This milestone reflects our long-term focus – translating advanced protein engineering into products that deliver real value beyond the lab.
Combining our expertise in protein engineering with Sollice Biotech’s capabilities in formulation and market deployment opens new opportunities for stabilized growth factors in modern dermocosmetics.
RegeNova®- XF2:
✔️ boosts collagen
✔️ activates fibroblasts
✔️ accelerates skin repair
✔️ improves firmness and elasticity
✔️ reduces visible signs of aging
We’re excited to see our technology reach new applications and become part of next-generation skincare solutions.